For almost six decades, Pharmathen has remained committed to its vision of improving patients’ lives through innovation and expanding access to complex pharmaceutical therapies.
Today, Pharmathen’s capabilities extend across a broad range of specialized dosage forms, including sustained-release products, long-acting injectables, and oral solid dosage forms, while its portfolio includes more than 100 commercial products available internationally through a strong network of partners.
These activities are supported by a robust Research & Development and Manufacturing ecosystem, with three facilities in Greece.
The driving force behind Pharmathen is its people. With more than 1,600 employees representing 27 nationalities, the company fosters a multicultural workplace where women account for 53% of the workforce and 40% of the Senior Leadership Team.
Grounded in its shared values of integrity, quality, innovation, leadership and performance, and guided by strong business ethics and a commitment to its vision, Pharmathen remains dedicated to its founding mission: improving patients’ lives.